TFO Wealth Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1
Closed -$404 481
2024
Q1
$404 Hold
1
﹤0.01% 310
2023
Q4
$307 Hold
1
﹤0.01% 510
2023
Q3
$240 Hold
1
﹤0.01% 736
2023
Q2
$240 Hold
1
﹤0.01% 458
2023
Q1
$188 Sell
1
-7
-88% -$1.45K ﹤0.01% 492
2022
Q4
$3K Buy
+8
New +$1.6K ﹤0.01% 213

Other funds holding MEDP

TFO Wealth Partners's MEDP Position: Q2 2024 in Review

TFO Wealth Partners sold out of Medpace (MEDP) in Q2 2024, closing a stake of 1 share — an estimated $404 sold.

TFO Wealth Partners first reported a position in MEDP in Q4 2022 and held it in 6 quarters. The position peaked at $3K in Q4 2022. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • TFO Wealth Partners reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • TFO Wealth Partners sold 1 Medpace share in Q2 2024, an estimated $404.
  • TFO Wealth Partners first reported a position in Medpace in Q4 2022 and held it in 6 quarters.
  • TFO Wealth Partners's Medpace position peaked at $3K in Q4 2022.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.